2010
Evaluation of the effects of everolimus‐eluting and paclitaxel‐eluting stents on target lesions with jailed side branches: 2‐year results from the SPIRIT III randomized trial
Applegate R, Hermiller J, Williams J, Gordon P, Doostzadeh J, Cao S, Su X, Sudhir K, Lansky A, Simonton C, Stone G. Evaluation of the effects of everolimus‐eluting and paclitaxel‐eluting stents on target lesions with jailed side branches: 2‐year results from the SPIRIT III randomized trial. Catheterization And Cardiovascular Interventions 2010, 76: 644-651. PMID: 20506356, DOI: 10.1002/ccd.22606.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryBiomarkersCardiovascular AgentsCoronary AngiographyCoronary Artery DiseaseCreatine Kinase, MB FormDrug-Eluting StentsEverolimusFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionMyocardiumNecrosisPaclitaxelProspective StudiesProsthesis DesignRisk AssessmentRisk FactorsSeverity of Illness IndexSingle-Blind MethodSirolimusTime FactorsTreatment OutcomeUnited StatesConceptsPaclitaxel-eluting stentsMajor adverse cardiac eventsTwo-year clinical outcomesTAXUS paclitaxel-eluting stentSPIRIT III trialXience V EESAdverse cardiac eventsMyocardial infarction rateUpper normal levelCreatine kinase-MBSide branchesLower ratesThinner stent strutsPeriprocedural increasePeriprocedural myonecrosisPES patientsEES groupIII trialsInfarction rateCardiac eventsSide branch compromiseCardiac deathPES groupClinical outcomesAdverse outcomes
2001
Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent
Bhargava B, Waksman R, Lansky A, Kornowski R, Mehran R, Leon M. Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent. Catheterization And Cardiovascular Interventions 2001, 54: 295-300. PMID: 11747152, DOI: 10.1002/ccd.1287.Peer-Reviewed Original ResearchConceptsMyocardial infarctionSB occlusionSide branch compromiseCoronary stentingClinical outcomesStent implantationNon-Q-wave myocardial infarctionLate major adverse eventsLong-term clinical outcomesSB compromiseLate target lesion revascularizationHospital ischemic complicationsMore myocardial infarctionsNIR stent implantationMajor adverse eventsTarget lesion revascularizationSide branch occlusionSB patencyBaseline patientIschemic complicationsLesion revascularizationRepeat revascularizationAdverse eventsConsecutive patientsProcedural success